Ovarian hormones and prolactin increase renal NaCl cotransporter phosphorylation

Am J Physiol Renal Physiol. 2015 Apr 15;308(8):F799-808. doi: 10.1152/ajprenal.00447.2014. Epub 2015 Jan 13.

Abstract

Unique situations in female physiology require volume retention. Accordingly, a dimorphic regulation of the thiazide-sensitive Na(+)-Cl(-) cotransporter (NCC) has been reported, with a higher activity in females than in males. However, little is known about the hormones and mechanisms involved. Here, we present evidence that estrogens, progesterone, and prolactin stimulate NCC expression and phosphorylation. The sex difference in NCC abundance, however, is species dependent. In rats, NCC phosphorylation is higher in females than in males, while in mice both NCC expression and phosphorylation is higher in females, and this is associated with increased expression and phosphorylation of full-length STE-20 proline-alanine-rich kinase (SPAK). Higher expression/phosphorylation of NCC was corroborated in humans by urinary exosome analysis. Ovariectomy in rats resulted in decreased expression and phosphorylation of the cotransporter and promoted the shift of SPAK isoforms toward the short inhibitory variant SPAK2. Conversely, estradiol or progesterone administration to ovariectomized rats restored NCC phosphorylation levels and shifted SPAK expression and phosphorylation towards the full-length isoform. Estradiol administration to male rats induced a significant increase in NCC phosphorylation. NCC is also modulated by prolactin. Administration of this peptide hormone to male rats induced increased phosphorylation of NCC, an effect that was observed even using the ex vivo kidney perfusion strategy. Our results indicate that estradiol, progesterone, and prolactin, the hormones that are involved in sexual cycle, pregnancy and lactation, upregulate the activity of NCC.

Keywords: WNK; distal convoluted tubule; hypertension; salt transport; thiazide.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Estradiol / administration & dosage
  • Estradiol / metabolism*
  • Estrogen Replacement Therapy
  • Female
  • Humans
  • Isoenzymes
  • Kidney / drug effects
  • Kidney / metabolism*
  • Male
  • Mice, Knockout
  • Ovariectomy
  • Ovary / metabolism*
  • Phosphorylation
  • Progesterone / administration & dosage
  • Progesterone / metabolism*
  • Prolactin / administration & dosage
  • Prolactin / metabolism*
  • Protein Serine-Threonine Kinases / metabolism
  • Rats, Wistar
  • Receptors, Prolactin / genetics
  • Receptors, Prolactin / metabolism
  • Sex Factors
  • Signal Transduction
  • Solute Carrier Family 12, Member 3 / drug effects
  • Solute Carrier Family 12, Member 3 / metabolism
  • Up-Regulation

Substances

  • Isoenzymes
  • Receptors, Prolactin
  • SLC12A3 protein, human
  • Slc12a3 protein, mouse
  • Slc12a3 protein, rat
  • Solute Carrier Family 12, Member 3
  • Progesterone
  • Estradiol
  • Prolactin
  • PAS domain kinases
  • Protein Serine-Threonine Kinases